Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seftor, E. A.
Right arrow Articles by Hendrix, M. J.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seftor, E. A.
Right arrow Articles by Hendrix, M. J.C.
[Cancer Research 65, 10164-10169, November 15, 2005]
© 2005 American Association for Cancer Research


Priority Reports

Epigenetic Transdifferentiation of Normal Melanocytes by a Metastatic Melanoma Microenvironment

Elisabeth A. Seftor1, Kevin M. Brown3, Lynda Chin4, Dawn A. Kirschmann1, William W. Wheaton1, Alexei Protopopov5, Bin Feng5, Yoganand Balagurunathan3, Jeffrey M. Trent3, Brian J. Nickoloff2, Richard E.B. Seftor1 and Mary J.C. Hendrix1

1 Children's Memorial Research Center and Robert H. Lurie Comprehensive Cancer Center at Northwestern University; 2 Department of Pathology, Loyola University of Chicago Medical Center, Chicago, Illinois; 3 Translational Genomics Research Institute, Phoenix, Arizona; 4 Dana-Farber Cancer Institute and Harvard Medical School; and 5 Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts

Requests for reprints: Mary J.C. Hendrix, Children's Memorial Research Center, 2300 Children's Plaza, Box 222, Chicago, IL 60614. Phone: 773-755-6528; Fax: 773-755-6594; E-mail: mjchendrix{at}childrensmemorial.org.

The clinical management of cutaneous melanoma would benefit significantly from a better understanding of the molecular changes that occur during melanocytic progression to a melanoma phenotype. To gain unique insights into this process, we developed a three-dimensional in vitro model that allows observations of normal human melanocytes interacting with a metastatic melanoma matrix to determine whether these normal cells could be reprogrammed by inductive cues in the tumor cell microenvironment. The results show the epigenetic transdifferentiation of the normal melanocytic phenotype to that of an aggressive melanoma-like cell with commensurate increased migratory and invasive ability with no detectable genomic alterations. Removal of the transdifferentiated melanocytes from the inductive metastatic melanoma microenvironment results in a reversion to their normal phenotype. However, a normal melanocyte microenvironment had no epigenetic influence on the phenotype of metastatic melanoma cells. This novel approach identifies specific genes involved in the transdifferentiation of melanocytes to a more aggressive phenotype, which may offer significant therapeutic value.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. M. Ghajar, V. Suresh, S. R. Peyton, C. B. Raub, F. L. Meyskens Jr., S. C. George, and A. J. Putnam
A novel three-dimensional model to quantify metastatic melanoma invasion
Mol. Cancer Ther., February 1, 2007; 6(2): 552 - 561.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. Carreira, J. Goodall, L. Denat, M. Rodriguez, P. Nuciforo, K. S. Hoek, A. Testori, L. Larue, and C. R. Goding
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Genes & Dev., December 15, 2006; 20(24): 3426 - 3439.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-M. Postovit, E. A. Seftor, R. E.B. Seftor, and M. J.C. Hendrix
Influence of the Microenvironment on Melanoma Cell Fate Determination and Phenotype
Cancer Res., August 15, 2006; 66(16): 7833 - 7836.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. M. Kulesa, J. C. Kasemeier-Kulesa, J. M. Teddy, N. V. Margaryan, E. A. Seftor, R. E. B. Seftor, and M. J. C. Hendrix
Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment
PNAS, March 7, 2006; 103(10): 3752 - 3757.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.